Molecular and Genetic Insights in Brain Tumors

Advances in the molecular classification of gliomas, medulloblastomas, and other CNS tumors.

Role of genetic mutations (e.g., IDH, EGFR, MGMT) in tumor progression and therapy response.

Innovations in Neuro-Oncological Diagnostics

Emerging neuroimaging techniques for precise tumor localization and monitoring.

Liquid biopsies and biomarkers for early detection and prognosis.

Surgical Advances in Neuro-Oncology

Innovations in minimally invasive and precision neurosurgical techniques.

Use of intraoperative imaging and navigation systems to enhance surgical outcomes.

Radiation and Chemotherapy in Neuro-Oncology

Advances in stereotactic radiosurgery and proton therapy for CNS tumors.

Exploring chemotherapeutic agents and their combination with radiotherapy for enhanced efficacy.

Immunotherapy and Targeted Therapies in Neuro-Oncology

Role of immune checkpoint inhibitors, CAR-T cell therapy, and vaccines in treating brain tumors.

Development of targeted therapies focusing on tumor-specific molecular pathways.

Tumor Microenvironment and Resistance Mechanisms

Understanding the role of the blood-brain barrier in therapy resistance.

Targeting the tumor microenvironment to improve therapeutic outcomes.

Pediatric Neuro-Oncology

Unique challenges in diagnosing and treating brain tumors in children.

Advances in therapy for medulloblastomas, ependymomas, and other pediatric CNS tumors.

Quality of Life and Survivorship in Neuro-Oncology

Addressing cognitive and functional impairments in neuro-oncology patients.

Supportive care strategies to improve quality of life during and after treatment.

5th International Conference on Neuroscience and Psychiatry